Fabio Piscaglia
Fabio Piscaglia
Associate Professor of Internal Medicine
Email verificata su unibo.it
TitoloCitata daAnno
The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications
F Piscaglia, C Nolsøe, CF Dietrich, DO Cosgrove, OH Gilja, MB Nielsen, ...
Ultraschall in der Medizin-European Journal of Ultrasound 33 (01), 33-59, 2012
10472012
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008
M Claudon, D Cosgrove, T Albrecht, L Bolondi, M Bosio, F Calliada, ...
Ultraschall in der Medizin-European Journal of Ultrasound 29 (01), 28-44, 2008
9772008
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012
M Claudon, CF Dietrich, BI Choi, DO Cosgrove, M Kudo, CP Nolsøe, ...
Ultraschall in der Medizin-European Journal of Ultrasound 34 (01), 11-29, 2013
9342013
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology
J Bamber, D Cosgrove, CF Dietrich, J Fromageau, J Bojunga, F Calliada, ...
Ultraschall in der Medizin-European Journal of Ultrasound 34 (02), 169-184, 2013
8372013
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications
D Cosgrove, F Piscaglia, J Bamber, J Bojunga, JM Correas, OH Gilja, ...
Ultraschall in der Medizin-European Journal of Ultrasound 34 (03), 238-253, 2013
7982013
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
L Bolondi, S Sofia, S Siringo, S Gaiani, A Casali, G Zironi, F Piscaglia, ...
Gut 48 (2), 251-259, 2001
7472001
EASL clinical practice guidelines: management of hepatocellular carcinoma
PR Galle, A Forner, JM Llovet, V Mazzaferro, F Piscaglia, JL Raoul, ...
Journal of hepatology 69 (1), 182-236, 2018
5852018
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
M Kudo, RS Finn, S Qin, KH Han, K Ikeda, F Piscaglia, A Baron, JW Park, ...
The Lancet 391 (10126), 1163-1173, 2018
5172018
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma
L Bolondi, S Gaiani, N Celli, R Golfieri, WF Grigioni, S Leoni, AM Venturi, ...
Hepatology 42 (1), 27-34, 2005
4652005
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization
JL Raoul, B Sangro, A Forner, V Mazzaferro, F Piscaglia, L Bolondi, ...
Cancer treatment reviews 37 (3), 212-220, 2011
4522011
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations
F Piscaglia, L Bolondi
Ultrasound in medicine & biology 32 (9), 1369-1375, 2006
4072006
Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential
T Knittel, D Kobold, B Saile, A Grundmann, K Neubauer, F Piscaglia, ...
Gastroenterology 117 (5), 1205-1221, 1999
3841999
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions
L Bolondi, A Burroughs, JF Dufour, PR Galle, V Mazzaferro, F Piscaglia, ...
Seminars in liver disease 32 (04), 348-359, 2012
3652012
Liver transplantation for hepatocellular carcinoma: results of down‐staging in patients initially outside the Milan selection criteria
M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ...
American Journal of Transplantation 8 (12), 2547-2557, 2008
3082008
What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy
S Gaiani, L Gramantieri, N Venturoli, F Piscaglia, S Siringo, A D'Errico, ...
Journal of hepatology 27 (6), 979-985, 1997
3081997
Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy
M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ...
Hepatology 54 (6), 2055-2063, 2011
3042011
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
G Donati, B Stagni, F Piscaglia, N Venturoli, AM Morselli-Labate, L Rasciti, ...
Gut 53 (7), 1020-1023, 2004
2912004
EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)
CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ...
Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017
2632017
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion
CF Dietrich, MA Averkiou, JM Correas, N Lassau, E Leen, F Piscaglia
Ultraschall in der Medizin-European Journal of Ultrasound 33 (04), 344-351, 2012
2352012
Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective …
F Piscaglia, L Bolondi
Ultrasound Med Biol 32 (9), 1369-1375, 2006
2332006
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20